Primary Record
NGI-1
- In stock
- 5,159 g
- Purity
- 99.1 %
- CAS
- 790702-57-7
Compound Identifiers & Properties
- CAS
- 790702-57-7
- PubChem CID
- 2519269
- SMILES
- CC1=CN=C(S1)NC(=O)C2=C(C=CC(=C2)S(=O)(=O)N(C)C)N3CCCC3
- Canonical SMILES
- Cc1cnc(NC(=O)c2cc(S(=O)(=O)N(C)C)ccc2N2CCCC2)s1
Names & Synonyms
- NGI-1
- 790702-57-7
- ML414
- NGI 1
- AC1M8RVC
- NGI1
- RefChem:531214
- MLS002248299
- 5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide
- KUC113535N-NLG
- orb1299880
- CHEMBL1720448
- SCHEMBL20598184
- SCHEMBL29377215
- cid_2519269
- C17H22N4O3S2
- MFCD06358908
- ML414; NGI-1
- NGI-1(ML414)
- QPKGRLIYJGBKJL-UHFFFAOYSA-N
- BDBM114446
- DTXSID601322912
- HMS3081P23
- KUC113535N
- N-linked Glycosylation Inhibitor-1
- NGI-1 (ML414)
- BCP29639
- EX-A2753
- ZINC3400706
- NGI-1 (ML414)?
- EBC-13177
- s8750
- ZB1632
- ZINC03400706
- SMR001315774
- AKOS017066633
- KUC113535N-02
- CID2519269
- NCGC00351072-01
- 5-(N,N-Dimethylsulfamoyl)-N-(5-methylthiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide
- AC-35603
- AS-73727
- BN164083
- KSC-367-096-1
- KSC-432-019-1
- HY-117383
- AK00792303
- CS-0065599
- J3.628.467F
- C76532
- EN300-182616
- N-0010
- A938282
- 5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-pyrrolidin-1-ylbenzamide
- BRD-K40795977-001-04-3
- BRD-K40795977-001-07-6
- Z29324102
- NGI1; NGI 1; ML414; ML 414; ML-414
- 5-[(Dimethylamino)sulfonyl]-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)benzamide
- 5-(dimethylsulfamoyl)-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)benzamide
- 5-(dimethylsulfamoyl)-N-(5-methylthiazol-2-yl)-2-pyrrolidin-1-yl-benzamide
- 5-(dimethylsulfamoyl)-N-(5-methylthiazol-2-yl)-2-pyrrolidino-benzamide
- N-(5-Methyl-2-thiazolyl)-3-(dimethylsulfamoyl)-6-pyrrolizinobenzamide
- 5-(dimethylsulfamoyl)-~{N}-(5-methyl-1,3-thiazol-2-yl)-2-pyrrolidin-1-yl-benzamide
- 5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benz amide
- 5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-pyrrolidin-1-yl-benzamide
- 839-712-9
- ZXT